Transplantology (Feb 2022)

Co-Infection of COVID-19 and Pneumocystosis Following Rituximab Infusion—A Case Report

  • Michelle Dakowitz,
  • Justyna Korus,
  • Oktawia Mazanowska,
  • Magdalena Krajewska,
  • Dorota Kamińska

DOI
https://doi.org/10.3390/transplantology3010008
Journal volume & issue
Vol. 3, no. 1
pp. 83 – 90

Abstract

Read online

Immunocompromised patients with respiratory viral infections are at increased risk of fungal superinfections, including Pneumocystosis. Within the scope of the COVID-19 pandemic, Pneumocystis jirovecii co-infections are being increasingly reported. Differential diagnosis often creates a dilemma, due to multiple overlapping clinical and radiographic features. Awareness of fungal co-infections in the context of the COVID-19 pandemic is crucial to initiate prophylactic measures, especially in high-risk individuals. We report the second case of Pneumocystis jirovecii pneumonia and COVID-19 co-infection in a renal transplant recipient in Poland.

Keywords